Funding for this research was provided by:
Guangzhou KingMed Translational Medicine Institute
State Key Laboratory of Respiratory Disease, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease
The Science and Technology Planning Project of Guangdong Province (2019B121205010)
Received: 29 March 2022
Accepted: 24 October 2022
First Online: 5 November 2022
: This study was approved by the institutional review board of KingMed Diagnostics with code 022.
: All the patients have signed an informed consent form.
: The authors declare that they have no competing interests.